1.

Patient-provider communication about medication use at the community pharmacy counter

2.

Patient-provider communication about medication use at the community pharmacy counter

3.

Patient-provider communication about medication use at the community pharmacy counter

4.

Patient-provider communication about medication use at the community pharmacy counter

1.

Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands

2.

Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands

3.

Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands

4.

Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands

1.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

2.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

3.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

4.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

5.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

6.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

7.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

8.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

9.

Workers on the line in small firms: Informal management and working-class clivages ; Les petites mains des petites entreprises : gestion informelle et fractures ouvrières

1.

Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects

2.

Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects

3.

Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects

4.

Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects

1.

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

2.

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

3.

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

4.

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

1.

Avaliação do impacto cutâneo associado à utilização recorrente de soluções antisséticas de base alcoólica (SABA) em profissionais de saúde

2.

Avaliação do impacto cutâneo associado à utilização recorrente de soluções antisséticas de base alcoólica (SABA) em profissionais de saúde

3.

Avaliação do impacto cutâneo associado à utilização recorrente de soluções antisséticas de base alcoólica (SABA) em profissionais de saúde

4.

Avaliação do impacto cutâneo associado à utilização recorrente de soluções antisséticas de base alcoólica (SABA) em profissionais de saúde

1.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

2.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

3.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

4.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

5.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

6.

Cadre juridique des conditions de délivrance des médicaments en Belgique, en France, au Luxembourg et en Suisse en vue du grand marché de 1993

1.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

2.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

3.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

4.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

5.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

6.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

7.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

8.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

9.

Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen

1.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

2.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

3.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

4.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

5.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

6.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

7.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

8.

Drug related problems and interventions of pharmacists on prescribed medicines in Belgium ; Problèmes reliés au traitement et interventions du pharmacien à propos des médicaments p...

1.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

2.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

3.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

4.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

5.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

6.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

7.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

8.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms

9.

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms